/주식/XENE
XENE

XENE

USD

Xenon Pharmaceuticals Inc. Common Shares

$39.090-0.650 (-1.636%)

실시간 가격

Healthcare
생명공학
캐나다

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$39.740

고가

$40.450

저가

$37.625

거래량

0.18M

기업 기본 정보

시가총액

3.0B

산업

생명공학

국가

Canada

거래 통계

평균 거래량

0.79M

거래소

NGM

통화

USD

52주 범위

저가 $26.74현재가 $39.090고가 $46

관련 뉴스

Analyst Upgrades

RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58

RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.

더 보기
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
Analyst Upgrades

Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44

Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.

더 보기
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Analyst Upgrades

Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target

Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.

더 보기
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
GlobeNewswire

Xenon to Report Q3 2025 Financial Results on November 3, 2025

VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and

더 보기
Xenon to Report Q3 2025 Financial Results on November 3, 2025